Intrinsiqs

Is Amylyx Pharmaceuticals, Inc. overvalued?

Amylyx Pharmaceuticals, Inc. (AMLX) — key valuation metrics and fundamentals.

No verdict
Price
$29.85
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$3.32B
Dividend yield
0.0%
Return on equity
-52.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AMLX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.